Test Bank - Introduction to Biotechnology, 3rd Edition
c c c c c c c c
(Thieman, 2013), Chapter 1-13 Complete Solutions
c c c c c c
Introduction cto cBiotechnology, c3e c(Thieman)
Chapter c1 c The cBiotechnology cCentury cand cIts cWorkforce
1) Scientists cat cthe cbiotechnology ccompany cGenentech ccreated cthe cfirst crecombinant cDNA
cproduct cfor cuse cin chumans. cApproved cby cthe cFood cand cDrug cAdministration cin c1982, cthis
cproduct cwas .
A) a cgene cchip
B) chymosin
C) insulin
D) human cgrowth chormone
E) erythropoietin
cAnswer: cC
2) Which carea cof cbiotechnology cprimarily cinvolves cusing cliving corganisms cto cprocess, cdegrade,
cand cclean cup cenvironmental cpollution?
A) Genomics
B) Bioinformatics
C) Bioremediation
D) Marine cbiotechnology
E) Agricultural cbiotechnology
cAnswer: cC
3) The cuse cof ccomputer chardware cand csoftware cto canalyze cbiological cdata, csuch cas cDNA
csequence ccomparison cdata, cis cknown cas .
A) genomics
B) bioinformatics
C) bioremediation
D) nanotechnology
E) recombinant cDNA ctechnology
cAnswer: cB
4) Studying cthe centire ccomplement cof cDNA cin can corganism's ccells cis cknown cas .
A) genomics
B) bioinformatics
C) bioremediation
D) nanotechnology
E) recombinant cDNA ctechnology
cAnswer: cA
5) Combining cDNA cfrom cdifferent csources cis can cexample cof .
A) genomics
B) bioinformatics
C) bioremediation
D) nanotechnology
E) recombinant cDNA ctechnology
,Answer: cE
,6) is ccustomized cmedicine cbased con ca cperson's cgenetics.
A) Genomics
B) Bioinformatics
C) Bioremediation
D) Pharmacogenomics
E) Recombinant cDNA ctechnology
cAnswer: cD
7) involves cfarm-raising cfinfish, cshellfish, calgae, cand cother caquatic corganisms.
A) Biopharming
B) Aquaculture
C) Pharmacogenomics
D) Bioremediation
E) Transgenic ctechnology
cAnswer: cB
8) is cthe cuse cof cgenes cfor ctreating chuman cgenetic cdisorders.
A) Genetics
B) Genomics
C) Pharmacogenomics
D) Gene ctherapy
E) Recombinant cDNA ctechnology
cAnswer: cD
9) Selective cbreeding cinvolves .
A) genetic cengineering cof canimals cand cplants cto cimprove cgrowth ccharacteristics
B) mating corganisms cwith cdesirable ccharacteristics
C) the cuse cof cfermentation cto cproduce cbiotechnology cproducts
D) combining csperm cand cegg ccells cfrom cdifferent cspecies cto cproduce chybrid corganisms
E) None cof cthese cchoices
cAnswer: cB
10) is cthe cuse cof cliving corganisms cor ctheir cproducts cto cclean cup cthe
cenvironment, cimprove chuman chealth, cand cprovide cmore cnutritious cand cdisease-free cfood.
A) Bioremediation
B) Biotechnology
C) Genetic cengineering
D) Biodegradation
E) Bioprocessing
cAnswer: cB
, 11) Subtle cdifferences cin cDNA csequences cthat cvary cfrom cperson cto cperson care ccalled .
A) genomics
B) chromosomes
C) DNA cmicroarrays
D) pharmacogenomics
E) single-nucleotide cpolymorphisms
cAnswer: cE
12) Explain cat cleast ctwo cdifferences cbetween ca ctraditional cpharmaceutical cproduct cand ca
cbiotechnology cproduct.
Answer: cA ctraditional cpharmaceutical cproduct cis ctypically ca csmall cmolecule csynthesized cby
cchemists cand cmade cinto ca cpill cform, cwhich ccan cbe corally cadministered cto ca cpatient
A cbiotechnology cproduct cis cusually ca clarge cmolecule cthat ccannot cbe csynthesized cor ctaken corally. cIt
cmust cbe cproduced cin ca ccell cline, cpurified cfrom cthe ccell cline, cand cultimately cformulated cto cbe
cadministered cto ca cpatient cby cinjection.
13) Discuss csome cexamples cof cdifferent cfields cof cbiotechnology cand cwhat cthey cstudy c(e.g.,
cbioremediation, cwhich cis cused cto cassist cin cthe cclean-up cof cchemical cspills, cetc.).
Answer: cAnswers ccan cvary.
cSome canswers cinclude:
• Microbial cbiotechnology, cwhich cis cused cin cmaking cfood
• Animal cbiotechnology, cwhich chelps cproduce cantibodies cin cthe cmilk cof cthe canimal
cwithout cdoing charm cto cthe canimal
• Forensic cbiotechnology, cwhich cis cuseful cin csolving ccrimes cand ctesting cpaternity
• Medical cbiotechnology, cwhich cinvolves cproducing cproducts cto cdiagnose, ctreat, cor ccure
ca cdisease
14) What care csome cnonscience cjob copportunities cin ca cbiotechnology ccompany? c Why cwould
cit cstill cbe cuseful cto chave csome cscience cbackground cfor cthese cpositions?
Answer: c Some cnonscience cbiotechnology cjobs cinclude cworking cin cregulatory caffairs, cmarketing,
csales, cand cthe clegal cdepartment cof cthe ccompany. cBecause cthe ccompany cproducts care cultimately
cbiological cin cnature, cemployees cwill cbetter cunderstand chow cto cdo ctheir cjobs cif cthey cknow cthe
cscience cas cwell. cFor cexample, cif ca csales crepresentative cdoes cnot cunderstand cany cof cthe cscience
cbehind cthe cproduct cthey care cselling, cthey ccannot ceasily canswer cany cquestions cthe cprescribing
cphysician cmight cask cthem.
Introduction cto cBiotechnology, c3e c(Thieman)
cChapter c2 c An cIntroduction cto cGenes cand cGenomes
1) The ccomplementary cbase cthat chydrogen cbonds cwith cthymine cin ca cDNA cdouble chelix cis
.
A) uracil
B) thymine
C) guanine
D) adenine
E) cytosine
cAnswer:
cD
c c c c c c c c
(Thieman, 2013), Chapter 1-13 Complete Solutions
c c c c c c
Introduction cto cBiotechnology, c3e c(Thieman)
Chapter c1 c The cBiotechnology cCentury cand cIts cWorkforce
1) Scientists cat cthe cbiotechnology ccompany cGenentech ccreated cthe cfirst crecombinant cDNA
cproduct cfor cuse cin chumans. cApproved cby cthe cFood cand cDrug cAdministration cin c1982, cthis
cproduct cwas .
A) a cgene cchip
B) chymosin
C) insulin
D) human cgrowth chormone
E) erythropoietin
cAnswer: cC
2) Which carea cof cbiotechnology cprimarily cinvolves cusing cliving corganisms cto cprocess, cdegrade,
cand cclean cup cenvironmental cpollution?
A) Genomics
B) Bioinformatics
C) Bioremediation
D) Marine cbiotechnology
E) Agricultural cbiotechnology
cAnswer: cC
3) The cuse cof ccomputer chardware cand csoftware cto canalyze cbiological cdata, csuch cas cDNA
csequence ccomparison cdata, cis cknown cas .
A) genomics
B) bioinformatics
C) bioremediation
D) nanotechnology
E) recombinant cDNA ctechnology
cAnswer: cB
4) Studying cthe centire ccomplement cof cDNA cin can corganism's ccells cis cknown cas .
A) genomics
B) bioinformatics
C) bioremediation
D) nanotechnology
E) recombinant cDNA ctechnology
cAnswer: cA
5) Combining cDNA cfrom cdifferent csources cis can cexample cof .
A) genomics
B) bioinformatics
C) bioremediation
D) nanotechnology
E) recombinant cDNA ctechnology
,Answer: cE
,6) is ccustomized cmedicine cbased con ca cperson's cgenetics.
A) Genomics
B) Bioinformatics
C) Bioremediation
D) Pharmacogenomics
E) Recombinant cDNA ctechnology
cAnswer: cD
7) involves cfarm-raising cfinfish, cshellfish, calgae, cand cother caquatic corganisms.
A) Biopharming
B) Aquaculture
C) Pharmacogenomics
D) Bioremediation
E) Transgenic ctechnology
cAnswer: cB
8) is cthe cuse cof cgenes cfor ctreating chuman cgenetic cdisorders.
A) Genetics
B) Genomics
C) Pharmacogenomics
D) Gene ctherapy
E) Recombinant cDNA ctechnology
cAnswer: cD
9) Selective cbreeding cinvolves .
A) genetic cengineering cof canimals cand cplants cto cimprove cgrowth ccharacteristics
B) mating corganisms cwith cdesirable ccharacteristics
C) the cuse cof cfermentation cto cproduce cbiotechnology cproducts
D) combining csperm cand cegg ccells cfrom cdifferent cspecies cto cproduce chybrid corganisms
E) None cof cthese cchoices
cAnswer: cB
10) is cthe cuse cof cliving corganisms cor ctheir cproducts cto cclean cup cthe
cenvironment, cimprove chuman chealth, cand cprovide cmore cnutritious cand cdisease-free cfood.
A) Bioremediation
B) Biotechnology
C) Genetic cengineering
D) Biodegradation
E) Bioprocessing
cAnswer: cB
, 11) Subtle cdifferences cin cDNA csequences cthat cvary cfrom cperson cto cperson care ccalled .
A) genomics
B) chromosomes
C) DNA cmicroarrays
D) pharmacogenomics
E) single-nucleotide cpolymorphisms
cAnswer: cE
12) Explain cat cleast ctwo cdifferences cbetween ca ctraditional cpharmaceutical cproduct cand ca
cbiotechnology cproduct.
Answer: cA ctraditional cpharmaceutical cproduct cis ctypically ca csmall cmolecule csynthesized cby
cchemists cand cmade cinto ca cpill cform, cwhich ccan cbe corally cadministered cto ca cpatient
A cbiotechnology cproduct cis cusually ca clarge cmolecule cthat ccannot cbe csynthesized cor ctaken corally. cIt
cmust cbe cproduced cin ca ccell cline, cpurified cfrom cthe ccell cline, cand cultimately cformulated cto cbe
cadministered cto ca cpatient cby cinjection.
13) Discuss csome cexamples cof cdifferent cfields cof cbiotechnology cand cwhat cthey cstudy c(e.g.,
cbioremediation, cwhich cis cused cto cassist cin cthe cclean-up cof cchemical cspills, cetc.).
Answer: cAnswers ccan cvary.
cSome canswers cinclude:
• Microbial cbiotechnology, cwhich cis cused cin cmaking cfood
• Animal cbiotechnology, cwhich chelps cproduce cantibodies cin cthe cmilk cof cthe canimal
cwithout cdoing charm cto cthe canimal
• Forensic cbiotechnology, cwhich cis cuseful cin csolving ccrimes cand ctesting cpaternity
• Medical cbiotechnology, cwhich cinvolves cproducing cproducts cto cdiagnose, ctreat, cor ccure
ca cdisease
14) What care csome cnonscience cjob copportunities cin ca cbiotechnology ccompany? c Why cwould
cit cstill cbe cuseful cto chave csome cscience cbackground cfor cthese cpositions?
Answer: c Some cnonscience cbiotechnology cjobs cinclude cworking cin cregulatory caffairs, cmarketing,
csales, cand cthe clegal cdepartment cof cthe ccompany. cBecause cthe ccompany cproducts care cultimately
cbiological cin cnature, cemployees cwill cbetter cunderstand chow cto cdo ctheir cjobs cif cthey cknow cthe
cscience cas cwell. cFor cexample, cif ca csales crepresentative cdoes cnot cunderstand cany cof cthe cscience
cbehind cthe cproduct cthey care cselling, cthey ccannot ceasily canswer cany cquestions cthe cprescribing
cphysician cmight cask cthem.
Introduction cto cBiotechnology, c3e c(Thieman)
cChapter c2 c An cIntroduction cto cGenes cand cGenomes
1) The ccomplementary cbase cthat chydrogen cbonds cwith cthymine cin ca cDNA cdouble chelix cis
.
A) uracil
B) thymine
C) guanine
D) adenine
E) cytosine
cAnswer:
cD
